• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: PD

ECG abnormalities may be PD risk factor

July 6, 2011  

First report of increased risk of prostate cancer in PD

June 29, 2011  

NMDA antagonists in Parkinson’s disease: meta-analysis

June 29, 2011  

Deep brain stimulation: consensus recommendations

March 9, 2011  

MoCA recommended to detect cognitive dysfunction in Parkinson’s disease

February 23, 2011  

Parkinson’s disease and melanoma: no genetic link

February 9, 2011  

Trial of pramipexole for depression in PD

December 8, 2010  

SCT in Parkinson’s disease

September 15, 2010  

Treatment of nonmotor symptoms: AAN report

September 1, 2010  

Trichloroethylene associated with PD risk

July 7, 2010  
Previous
3
4
5
6
7
Next

Browse by Topic

  • EPILEPSY (36)
  • MS (412)
  • CLINICAL CASES IN MS (15)
  • BIOMARKERS IN MS (54)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Treatment discontinuation in MS: the DOT-MS trial posted on May 5, 2025
  • AAN 2025 – report on fluid biomarkers in MS posted on April 22, 2025
  • McDonald criteria 2024: what changes can we expect? posted on January 30, 2024
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions